Adjustments in dosing and monitoring are important during the transition
The retained water can put pressure on neurovascular structures, leading to numbness and tingling in the extremities, and in some cases, symptoms resembling carpal tunnel syndrome
Heart Failure Protection Recent studies indicate that GLP-1 therapies may improve heart failure outcomes , particularly in people with preserved ejection fraction (HFpEF)
Patients should: Weigh themselves once weekly at the same time and under consistent conditions Record measurements in a diary or app to identify trends Aim for gradual weight loss (NHS advises 0.51 kg per week is generally safe and sustainable) Understand that response to GLP-1 therapy varies between individuals Report unexpected rapid weight loss or gain to their healthcare provider It is important to recognise that weight loss may plateau after several months, and this does not necessarily indicate treatment failure
Anyone participating in a trial should follow the schedule set by their clinical team precisely, including guidance on what to do if a dose is missed, rather than making independent decisions about timing or frequency
With the right support, weight loss becomes easier to maintain and part of a healthy lifestyle